Cognex Corporation (CGNX)

In the past six months, Cognex Corp. stock has experienced several notable events, including earnings reports, dividend declarations, and analyst rating changes. Cognex reported its Third Quarter 2025 results on October 29, 2025, and its Second Quarter 2025 results on July 30, 2025. Cognex declared quarterly cash dividends payable on November 28, 2025, and August 28, 2025. Analyst ratings have varied, with Barclays affirming an "Overweight" rating but lowering its price target, Truist Securities maintaining a "Hold" rating and lowering its price target, Goldman Sachs upgrading its rating to "Buy" and raising the price target, and JP Morgan downgrading the stock to "Underweight" and revising its price target. Cognex Corporation was dropped from the Russell Small Cap Comp Growth Index and the Russell 3000E Growth Index around June 29-30, 2025. CGNX stock has risen by 5.77% compared to the previous week, 6.68% over the last month, and 7.43% over the last year.

Cognex Corp. experiences demand seasonality for its products and services, which can vary across its different end markets. The consumer electronics segment exhibits seasonality, with revenue sometimes shifting between quarters. The fourth quarter is generally expected to return to typical seasonal patterns, often resulting in a high single-digit sequential revenue decline. Demand in the automotive sector has been a weakness, while logistics and packaging have shown strong growth. The semiconductor business is experiencing healthy growth.

Cognex Corporation specializes in machine vision products and solutions, operating within the Technology sector. The company invents and commercializes technologies that enable computers to analyze visual information for automating tasks in manufacturing and distribution. Its major products include vision systems, vision sensors, vision software, ID readers, and In-Sight systems, which are crucial for automating the manufacturing, distribution, and tracking of discrete items.

Cognex Corporation is headquartered in Natick, Massachusetts, USA, and maintains offices in over 20 countries, serving more than 30,000 customers worldwide. The company's operations are segmented geographically into the United States, Europe, Greater China, and Other regions, with the United States and Europe accounting for the largest proportion of its sales.

Cognex has maintained a strong brand reputation, emphasizing its position as a technology leader with deep domain expertise and continuous investment in AI. The company is focused on making advanced machine vision accessible and easier to deploy through AI, helping factories and warehouses improve quality and maximize efficiency. Cognex is targeting to be the number one provider of AI technology for industrial machine vision applications. A revamped go-to-market strategy has led to broader reach and new customer acquisition. A new commercial partnership targeting medical lab automation is expected to boost revenue. Management has highlighted a step-change in profitability and operational discipline, with a focus on cost control.

The ownership structure of Cognex Corp. is primarily held by institutional investors, who collectively own between 88.12% and 95.54% of the company's stock. Major institutional holders include Vanguard Group Inc., BlackRock, Inc., Nordea Investment Management Ab, Pictet Asset Management Holding SA, State Street Corp, and T. Rowe Price Investment Management, Inc. Company insiders own approximately 0.28% to 3.78% of the stock, with Dr. Robert J. Shillman being the largest individual shareholder. Retail investors hold a smaller portion, ranging from 0.68% to 25.66%.